Understanding yellow fever-associated myocardial injury: an autopsy study

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorGIUGNI, Fernando Rabioglio
dc.contributor.authorDEMARCHIAIELLO, Vera
dc.contributor.authorFARIA, Caroline Silverio
dc.contributor.authorPOUR, Shahab Zaki
dc.contributor.authorCUNHA, Marielton dos Passos
dc.contributor.authorGIUGNI, Melina Valdo
dc.contributor.authorPINESI, Henrique Trombini
dc.contributor.authorLEDESMA, Felipe Lourenco
dc.contributor.authorMORAIS, Carolina Esteves
dc.contributor.authorHO, Yeh-Li
dc.contributor.authorSZTAJNBOK, Jaques
dc.contributor.authorFERNEZLIAN, Sandra de Morais
dc.contributor.authorSILVA, Luiz Fernando Ferraz da
dc.contributor.authorMAUAD, Thais
dc.contributor.authorALVES, Venancio Avancini Ferreira
dc.contributor.authorSALDIVA, Paulo Hilario do Nascimento
dc.contributor.authorANTONANGELO, Leila
dc.contributor.authorDOLHNIKOFF, Marisa
dc.contributor.authorDUARTE-NETO, Amaro Nunes
dc.date.accessioned2023-12-15T18:56:25Z
dc.date.available2023-12-15T18:56:25Z
dc.date.issued2023
dc.description.abstractBackground Yellow fever (YF) is a viral hemorrhagic fever, endemic in parts of South America and Africa. There is scarce evidence about the pathogenesis of the myocardial injury. The objective of this study is to evaluate the cardiac pathology in fatal cases of YF.Methods This retrospective autopsy study included cases from the Sao Paulo (Brazil) epidemic of 2017-2019. We reviewed medical records and performed cardiac tissue histopathological evaluation, electron microscopy, immunohistochemical assays, RT-qPCR for YF virus (YFV)-RNA, and proteomics analysis on inflammatory and endothelial biomarkers.Findings Seventy-three confirmed YF cases with a median age of 48 (34-60) years were included. We observed myocardial fibrosis in 68 (93.2%) patients; cardiomyocyte hypertrophy in 68 (93.2%); endothelial alterations in 67 (91.8%); fiber necrosis in 50 (68.5%); viral myocarditis in 9 (12.3%); and secondary myocarditis in 5 (6.8%). Four out of five patients with 17DD vaccine-associated viscerotropic disease presented with myocarditis. The cardiac conduction system showed edema, hemorrhages and endothelial fibrinoid necrosis. Immunohistochemistry detected CD68-positive inflammatory interstitial cells and YFV antigens in endothelial and inflammatory cells. YFV-RNA was detected positive in 95.7% of the cardiac samples. The proteomics analysis demonstrated that YF patients had higher levels of multiple inflammatory and endothelial biomarkers in comparison to cardiovascular controls, and higher levels of interferon gamma-induced protein 10 (IP-10) in comparison to sepsis (p = 0.01) and cardiovascular controls (p < 0.001) in Dunn test.Interpretation Myocardial injury is frequent in severe YF, due to multifactorial mechanisms, including direct YFV-mediated damage, endothelial cell injury, and inflammatory response, with a possible prominent role for IP-10.eng
dc.description.indexMEDLINE
dc.description.indexPubMed
dc.description.indexWoS
dc.description.indexScopus
dc.description.sponsorshipFundacao de Amparo a Pesquisa do Estado de Sao Paulo
dc.description.sponsorshipBill and Melinda Gates Foundation
dc.description.sponsorshipConselho Nacional de Desenvolvimento Cientifico e Tecnologico
dc.description.sponsorshipCoordenacao de Aperfeicoamento dePessoal de Nivel Superior
dc.identifier.citationEBIOMEDICINE, v.96, article ID 104810, 15p, 2023
dc.identifier.doi10.1016/j.ebiom.2023.104810
dc.identifier.issn2352-3964
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/57527
dc.language.isoeng
dc.publisherELSEVIEReng
dc.relation.ispartofEbiomedicine
dc.rightsrestrictedAccesseng
dc.rights.holderCopyright ELSEVIEReng
dc.subjectYellow fevereng
dc.subject17DDeng
dc.subjectYEL-AVDeng
dc.subjectMyocarditiseng
dc.subjectHeart conduction systemeng
dc.subjectVascular endotheliumeng
dc.subjectCytokineseng
dc.subjectChemokineseng
dc.subjectIP-10eng
dc.subjectAutopsyeng
dc.subject.othersepsiseng
dc.subject.otherdysfunctioneng
dc.subject.othervaccineeng
dc.subject.otherdiseaseeng
dc.subject.wosMedicine, General & Internaleng
dc.subject.wosMedicine, Research & Experimentaleng
dc.titleUnderstanding yellow fever-associated myocardial injury: an autopsy studyeng
dc.typearticleeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.author.externalPOUR, Shahab Zaki:Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, Lab Evolucao Mol & Bioinformat, Sao Paulo, SP, Brazil
hcfmusp.author.externalCUNHA, Marielton dos Passos:Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, Lab Evolucao Mol & Bioinformat, Sao Paulo, SP, Brazil
hcfmusp.author.externalSZTAJNBOK, Jaques:Inst Infectol Emilio Ribas, Sao Paulo, SP, Brazil
hcfmusp.citation.scopus0
hcfmusp.contributor.author-fmusphcFERNANDO RABIOGLIO GIUGNI
hcfmusp.contributor.author-fmusphcVERA DEMARCHI AIELLO
hcfmusp.contributor.author-fmusphcCAROLINE SILVERIO FARIA
hcfmusp.contributor.author-fmusphcMELINA DE OLIVEIRA VALDO
hcfmusp.contributor.author-fmusphcHENRIQUE TROMBINI PINESI
hcfmusp.contributor.author-fmusphcFELIPE LOURENCO LEDESMA
hcfmusp.contributor.author-fmusphcCAROLINA ESTEVES DE MORAIS
hcfmusp.contributor.author-fmusphcHO YEH LI
hcfmusp.contributor.author-fmusphcSANDRA DE MORAIS FERNEZLIAN
hcfmusp.contributor.author-fmusphcLUIZ FERNANDO FERRAZ DA SILVA
hcfmusp.contributor.author-fmusphcTHAIS MAUAD
hcfmusp.contributor.author-fmusphcVENANCIO AVANCINI FERREIRA ALVES
hcfmusp.contributor.author-fmusphcPAULO HILARIO NASCIMENTO SALDIVA
hcfmusp.contributor.author-fmusphcLEILA ANTONANGELO
hcfmusp.contributor.author-fmusphcMARISA DOLHNIKOFF
hcfmusp.contributor.author-fmusphcAMARO NUNES DUARTE NETO
hcfmusp.description.articlenumber104810
hcfmusp.description.volume96
hcfmusp.origemWOS
hcfmusp.origem.pubmed37757571
hcfmusp.origem.scopus2-s2.0-85171971862
hcfmusp.origem.wosWOS:001085240500001
hcfmusp.publisher.cityAMSTERDAMeng
hcfmusp.publisher.countryNETHERLANDSeng
hcfmusp.relation.referenceAkwii RG, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050471eng
hcfmusp.relation.referenceAlvarez Maria Fernanda, 2017, F1000Res, V6, P390, DOI 10.12688/f1000research.11078.1eng
hcfmusp.relation.referenceAmalakuhan B, 2016, CYTOKINE, V88, P267, DOI 10.1016/j.cyto.2016.08.028eng
hcfmusp.relation.reference[Anonymous], 2017, Wkly Epidemiol Rec, V92, P193eng
hcfmusp.relation.reference[Anonymous], SINANWEB-Febre Amarelaeng
hcfmusp.relation.reference[Anonymous], Dados Estatisticos-Secretaria da Saude-Governo do Estado de Sao Pauloeng
hcfmusp.relation.referenceBarreto-Vieira DF, 2020, MEM I OSWALDO CRUZ, V115, DOI 10.1590/0074-02760200278eng
hcfmusp.relation.referenceBasso C, 2020, EUR HEART J, V41, P3827, DOI 10.1093/eurheartj/ehaa664eng
hcfmusp.relation.referenceBi CF, 2022, J INFLAMM RES, V15, P4275, DOI [10.2147/JIR.S374117, 10.2147/JIR.S374117Journalof]eng
hcfmusp.relation.referenceChan RC, 2001, LANCET, V358, P121, DOI 10.1016/S0140-6736(01)05341-7eng
hcfmusp.relation.referenceChen Y, 2020, MOL MED, V26, DOI 10.1186/s10020-020-00230-xeng
hcfmusp.relation.referenceChung MK, 2021, CIRC RES, V128, P1214, DOI 10.1161/CIRCRESAHA.121.317997eng
hcfmusp.relation.referenceCunha MD, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56650-1eng
hcfmusp.relation.referencede Avila RE, 2020, INT J INFECT DIS, V93, P90, DOI 10.1016/j.ijid.2020.01.039eng
hcfmusp.relation.referencede-Oliveira-Pinto LM, 2012, MEM I OSWALDO CRUZ, V107, P48, DOI 10.1590/S0074-02762012000100007eng
hcfmusp.relation.referenceDEBRITO T, 1992, PATHOL RES PRACT, V188, P177, DOI 10.1016/S0344-0338(11)81176-3eng
hcfmusp.relation.referenceDeSilva M, 2015, MMWR-MORBID MORTAL W, V64, P279eng
hcfmusp.relation.referenceDuarte-Neto AN, 2019, HISTOPATHOLOGY, V75, P638, DOI 10.1111/his.13904eng
hcfmusp.relation.referenceDuarte-Neto AN, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007625eng
hcfmusp.relation.referenceElemam NM, 2022, VIRUSES-BASEL, V14, DOI 10.3390/v14112445eng
hcfmusp.relation.referenceFabro AT, 2019, AM J RESP CRIT CARE, V200, P250, DOI 10.1164/rccm.201711-2267IMeng
hcfmusp.relation.referenceFernandes EG, 2023, EMERG INFECT DIS, V29, P493, DOI 10.3201/eid2903.220989eng
hcfmusp.relation.referenceHabimana R, 2020, ACUTE CRIT CARE, V35, P57, DOI 10.4266/acc.2020.00248eng
hcfmusp.relation.referenceHo YL, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/taz040eng
hcfmusp.relation.referenceKallas EG, 2019, LANCET INFECT DIS, V19, P750, DOI 10.1016/S1473-3099(19)30125-2eng
hcfmusp.relation.referenceKhongphatthanayothin A, 2005, SHOCK, V24, P407, DOI 10.1097/01.shk.0000180981.70870.8ceng
hcfmusp.relation.referenceLaBeaud AD, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000847eng
hcfmusp.relation.referenceLaBeaud AD, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000247eng
hcfmusp.relation.referenceLambden S, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2102-1eng
hcfmusp.relation.referenceLi S, 2022, J Virol, V96eng
hcfmusp.relation.referenceLloyd W, 1931, AM HEART J, V6, P504, DOI 10.1016/S0002-8703(31)90034-3eng
hcfmusp.relation.referenceLloyd W, 1931, AM HEART J, V6, P483, DOI 10.1016/S0002-8703(31)90033-1eng
hcfmusp.relation.referenceMerx MW, 2007, CIRCULATION, V116, P793, DOI 10.1161/CIRCULATIONAHA.106.678359eng
hcfmusp.relation.referenceMinhas AM, 2017, CUREUS J MED SCIENCE, V9, DOI 10.7759/cureus.1399eng
hcfmusp.relation.referenceMiranda CH, 2013, EUR HEART J-ACUTE CA, V2, P127, DOI 10.1177/2048872613475889eng
hcfmusp.relation.referenceMonath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030eng
hcfmusp.relation.referencePaixao GMM, 2019, AM J CARDIOL, V123, P833, DOI 10.1016/j.amjcard.2018.11.032eng
hcfmusp.relation.referencePuerta-Guardo H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005738eng
hcfmusp.relation.referenceRocha-Lima H, 1912, Verh dtsch path, V15, P163eng
hcfmusp.relation.referenceSemsarian C, 2016, J ARRYTHM, V32, P359, DOI 10.1016/j.joa.2015.09.010eng
hcfmusp.relation.referenceSow A, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1100-5eng
hcfmusp.relation.referenceSun T, 2022, FRONT PUBLIC HEALTH, V10, DOI 10.3389/fpubh.2022.870065eng
hcfmusp.relation.referenceTuells J, 2022, ARCH MED RES, V53, P649, DOI 10.1016/j.arcmed.2022.10.005eng
hcfmusp.relation.referenceVasconcelos PFC, 2001, LANCET, V358, P91, DOI 10.1016/S0140-6736(01)05326-0eng
hcfmusp.scopus.lastupdate2024-04-12
relation.isAuthorOfPublication6bc84a15-5eb1-45a7-938e-f982121c1db0
relation.isAuthorOfPublicationd105992d-35d0-4e8b-a262-610c52ff58f4
relation.isAuthorOfPublication7c449469-e376-4cbe-8451-7cc89b73ef1d
relation.isAuthorOfPublication7e0b1d39-1a68-4d01-befa-69c1582dc08d
relation.isAuthorOfPublicationbd5b74ea-0f97-4a4f-8d10-c5038caf1eac
relation.isAuthorOfPublication791e979a-1a21-403e-8879-b23137919a11
relation.isAuthorOfPublicationf2a57223-f613-405d-b216-de223cbedd0b
relation.isAuthorOfPublication0214ce00-5115-4ded-8bcd-e219f9287479
relation.isAuthorOfPublication004de5ed-ac42-4096-a56e-60aba6cf1ee3
relation.isAuthorOfPublication0d4c5e63-ea43-4e35-9812-ff30ff292ef7
relation.isAuthorOfPublicationf5944efe-ce9e-46ee-ba65-1728b688ab3b
relation.isAuthorOfPublicationdd94c553-33a7-4e49-9541-3c998006d016
relation.isAuthorOfPublicationcb8ac601-f702-4f9a-9d07-7f10579e68d5
relation.isAuthorOfPublication02769cb7-5644-4d8b-b9bc-60221e051b83
relation.isAuthorOfPublication136d0bce-36c6-4155-a113-4527576eba68
relation.isAuthorOfPublication01caf18a-6e85-42e6-9d58-52f78bf229b5
relation.isAuthorOfPublication.latestForDiscovery6bc84a15-5eb1-45a7-938e-f982121c1db0
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
art_GIUGNI_Understanding_yellow_feverassociated_myocardial_injury_an_autopsy_study_2023.PDF
Tamanho:
5.87 MB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)